Formononetin-induced apoptosis of human prostate cancer cells through ERK1/2 mitogen-activated protein kinase inactivation

Hormone and Metabolic Research

Volumn 44, Issue 4, 2012, Pages 263-267

  Ye, Y ^a   Hou, R ^b   Chen, J ^c   Mo, L ^a   Zhang, J ^a   Huang, Y ^a   Mo, Z ^a  

^a GUANGXI MEDICAL UNIVERSITY   (China)

^b XINXIANG MEDICAL UNIVERSITY   (China)

^c GUILIN MEDICAL UNIVERSITY   (China)

Author keywords

ERK1 2; formononetin; IGF 1R; phytoestrogen; prostate cancer

Indexed keywords

FORMONONETIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN BAX; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL STRAIN LNCAP; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION;

APOPTOSIS; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; CELL PROLIFERATION; ENZYME ACTIVATION; HUMANS; ISOFLAVONES; MALE; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PLANT EXTRACTS; PROSTATIC NEOPLASMS; TRIFOLIUM;

TRIFOLIUM PRATENSE;

EID: 84862808909     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0032-1301922     Document Type: Article

References (29)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun M J. Cancer Statistics 2007. CA Cancer J Clin. 2007; 57 43 66
2. McCracken M, Olsen M, Chen M S Jr, Jemal A, Thun M, Cokkinides V, Deapen D, Ward E. Cancer incidence, mortality, and associated risk factors among Asian Americans of Chinese, Filipino, Vietnamese, Korean, and Japanese ethnicities. CA Cancer J Clin: 2007; 57 190 205 (Pubitemid 47312080)
3. Nakamura H, Wang Y, Kurita T, Adomat H, Cunha G R, Wang Y. Genistein increases epidermal growth factor receptor signaling and promotes tumor progression in advanced human prostate cancer. PLoS One: 2011; 6 e20034
4. Ward H A, Kuhnle G G, Mulligan A A, Lentjes M A, Luben R N, Khaw K T. Breast, colorectal, and prostate cancer risk in the European Prospective Investigation into Cancer and Nutrition-Norfolk in relation to phytoestrogen intake derived from an improved database. Am J Clin Nutr: 2010; 91 440 448
5. Zhao R, Xiang N, Domann F E, Zhong W. Effects of selenite and genistein on G2/M cell cycle arrest and apoptosis in human prostate cancer cells. Nutr Cancer: 2009; 61 397 407
6. Alhasan S A, Pietrasczkiwicz H, Alonso M D, Ensley J, Sarkar F H. Genistein-induced cell cycle arrest and apoptosis in a head and neck squamous cell carcinoma cell line. Nutr Cancer: 1999; 34 12 19 (Pubitemid 29382910)
7. Fotsis T, Pepper M, Adlercreutz H, Fleischmann G, Hase T, Montesano R, Schweigerer L. Genistein, a dietary-derived inhibitor of in vitro angiogenesis. Proc Natl Acad Sci USA: 1993; 90 2690 2694 (Pubitemid 23113482)
8. Lüke C, Krott R, Lüke M, Lebek J, Walter P, Brunner R, Sickel W. Effects of protein tyrosine kinase inhibitor genistein on retinal function in superfused vertebrate retina. J Ocul Pharmacol Ther: 2001; 17 151 158 (Pubitemid 32299079)
9. Markovits J, Linassier C, Foss P, Couprie J, Pierre J, Jacquemin-Sablon A, Saucier J M, Le Pecq J B, Larsen A K. Inhibitory effects of the tyrosine kinase inhibitor genistein on mammalian DNA topoisomerase II. Cancer Res: 1989; 49 5111 5117 (Pubitemid 19239354)
10. Brown N M, Wang J, Cotroneo M S, Zhao Y X, Lamartiniere C A. Prepubertal genistein treatment modulates TGF-alpha, EGF and EGF-receptor mRNAs and proteins in the rat mammary gland. Mol Cell Endocrinol: 1998; 144 149 165 (Pubitemid 28491310)
11. Chen J, Zeng J, Xin M, Huang W, Chen X. Formononetin induces cell cycle arrest of human breast cancer cells via IGF1/PI3K/Akt pathways in vitro and in vivo. Horm Metab Res: 2011; 43 681 686
12. Fang J, Zhou Q, Shi X L, Jiang B H. Luteolin inhibits insulin-like growth factor 1 receptor signaling in prostate cancer cells. Carcinogenesis: 2007; 28 713 723 (Pubitemid 46523369)
13. Chen J, Deng F, Singh S V, Wang Q J. Protein kinase D3 (PKD3) contributes to prostate cancer cell growth and survival through a PKCepsilon/PKD3 pathway downstream of Akt and ERK 1/2. Cancer Res: 2008; 68 3844 3853
14. Smith S, Sepkovic D, Bradlow H L, Auborn K J. 3,3-Diindolylmethane and genistein decrease the adverse effects of estrogen in LNCaP and PC-3 prostate cancer cells. J Nutr: 2008; 138 2379 2385
15. Hara T, Miyazaki H, Lee A, Tran C P, Reiter R E. Androgen receptor and invasion in prostate cancer. Cancer Res: 2008; 68 1128 1135 (Pubitemid 351272231)
16. Suzuki H, Ueda T, Ichikawa T, Ito H. Androgen receptor involvement in the progression of prostate cancer. Endocr Relat Cancer. 2003; 10 209 216
17. Linja M J, Savinainen K J, Tammela T L, Isola J J, Visakorpi T. Expression of ERalpha and ERbeta in prostate cancer. Prostate: 2003; 55 180 186 (Pubitemid 36532396)
18. Chen J, Liu L, Hou R, Shao Z, Wu Y, Chen X, Zhou L. Calycosin promotes proliferation of estrogen receptor-positive cells via estrogen receptors and ERK1/2 activation in vitro and in vivo. Cancer Lett: 2011; 308 144 151
19. Fang J, Zhou Q, Shi X L, Jiang B H. Luteolin inhibits insulin-like growth factor 1 receptor signaling in prostate cancer cells. Carcinogenesis: 2007; 28 713 723 (Pubitemid 46523369)
20. Dos Santos E, Dieudonn M N, Leneveu M C, Srazin V, Rincheval V, Mignotte B, Chouillard E, De Mazancourt P, Giudicelli Y, Pecquery R. Effects of 17beta-estradiol on preadipocyte proliferation in human adipose tissue: Involvement of IGF1-R signaling. Horm Metab Res: 2010; 42 514 520
21. Koul H K, Maroni P D, Meacham R B, Crawford D, Koul S. p42/p44 Mitogen-activated protein kinase signal transduction pathway: a novel target for the treatment of hormone-resistant prostate cancer? Ann N Y Acad Sci: 2004; 1030 243 252 (Pubitemid 40378919)
22. Makarevich A V, Sirotkin A V, Rafay J. Comparison of effects of protein kinase A, mitogen-activated protein kinase, and cyclin-dependent kinase blockers on rabbit ovarian granulosa cell functions. Horm Metab Res: 2010; 42 936 943
23. Fan Y, Chen H, Qiao B, Luo L, Ma H, Li H, Jiang J, Niu D, Yin Z. Opposing effects of ERK and p38 MAP kinases on HeLa cell apoptosis induced by dipyrithione. Mol Cells: 2007; 23 30 38 (Pubitemid 46443895)
24. Marshall C J. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell: 1995; 80 179 185
25. Roovers K, Assoian R K. Integrating the MAP kinase signal into the G1 phase cell cycle machinery. Bioessays: 2000; 22 818 826
26. Weidinger C, Karger S, Krause K, Schierle K, Steinert F, Gimm O, Dralle H, Fuhrer D. Distinct regulation of intrinsic apoptosis in benign and malignant thyroid tumours. Horm Metab Res: 2010; 42 553 556
27. Adams J M, Cory S. Life-or-death decisions by the Bcl-2 protein family. Trends Biochem Sci: 2001; 26 61 66 (Pubitemid 32124712)
28. Borner C. The Bcl-2 protein family: sensors and checkpoints for life-or-death decisions. Mol Immunol: 2003; 39 615 647 (Pubitemid 35454076)
29. Li Y X, Jiang B, Li Y, Xia F, Yu J, Yang L Z, Shi C, Lu Y L. Mitochondrial apoptotic pathways: a mechanism for low androgen-induced vascular endothelial injury in male rats. Horm Metab Res: 2011; 43 374 379